STOCK TITAN

KNOWLES CORPORATION 8-K Filings

KN NYSE

Every 8-K that KNOWLES CORPORATION (KN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow KN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KN filings page.

Rhea-AI Summary

Knowles Corporation updates its disclosure regarding stockholder advisory votes on executive compensation. Following the 2026 Annual Meeting of Stockholders held on April 28, 2026, where stockholders favored annual Say-On-Pay votes, the Board of Directors determined that future Say-On-Pay votes will be held every year. This annual schedule will continue until the next stockholder advisory vote on Say-On-Pay frequency, which will occur no later than the 2032 Annual Meeting of Stockholders. No other aspects of the previously reported 2026 annual meeting voting results are changed by this amendment.

Rhea-AI Summary

Knowles Corporation reported strong second quarter 2026 results from continuing operations, with revenue of $166.8 million, up 14% year over year, and gross margin of 44.7%. Diluted EPS from continuing operations rose to $0.21, while non-GAAP diluted EPS increased 38% to $0.33. Adjusted earnings before interest and income taxes were $36.1 million, and Adjusted EBITDA reached $41.8 million, a 25.1% margin. Net cash provided by operating activities was $28.2 million. Growth was led by the Precision Devices segment, which generated revenue of $98.3 million and a 25.2% year-over-year increase, while Medtech & Specialty Audio revenue was $68.5 million; this was the seventh consecutive quarter with a book-to-bill greater than one.

Management now expects 2026 revenues to grow 10–12% with adjusted EBITDA growth of more than 20%, citing increasing bookings, new design wins, and a healthy backlog across Medtech, Defense, Industrial, and Electrification end markets. For the third quarter of 2026, Knowles guides revenue from continuing operations of $167 to $177 million, GAAP diluted EPS of $0.22 to $0.26, non-GAAP diluted EPS of $0.34 to $0.38, and operating cash flow of $35 to $45 million. The balance sheet shows cash of $49.6 million, long-term debt of $131.0 million, net debt of $81.4 million, and a net debt leverage ratio of 0.5x.

Rhea-AI Summary

Knowles Corporation reported the results of its annual stockholders meeting held on April 28, 2026. Stockholders elected eight directors to one-year terms, with each nominee receiving a strong majority of votes cast.

Investors also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers. In a separate advisory vote on how often to hold future say-on-pay votes, stockholders supported an annual (every year) frequency. Finally, stockholders ratified PricewaterhouseCoopers LLP as Knowles’ independent registered public accounting firm for 2025, with a very high level of support and minimal opposition.

Rhea-AI Summary

Knowles Corporation reported strong Q1 2026 results with solid growth and margin improvement. Revenue from continuing operations was $153.1 million, up about 16% year over year, while non-GAAP diluted EPS from continuing operations rose 50% to $0.27 and GAAP diluted EPS reached $0.13. GAAP gross margin improved to 43.8%, with non-GAAP gross margin at 45.5%, reflecting better mix and factory utilization. MedTech & Specialty Audio revenue grew 13.9% and Precision Devices revenue grew 17.4%, both expanding adjusted EBITDA margins. Adjusted EBITDA from continuing operations was $35.3 million, a 23.1% margin. Despite strong earnings, net cash used in operating activities was $0.7 million, and adjusted free cash flow was negative $3.1 million. For Q2 2026, the company guides revenue of $152 to $162 million, non-GAAP diluted EPS of $0.28 to $0.32, and net cash from operating activities of $20 to $30 million.

Rhea-AI Summary

Knowles Corporation reported that its Board’s Compensation Committee granted a special equity award of performance share units (PSUs) to Chief Operating Officer Daniel J. Giesecke under the 2018 Equity and Cash Incentive Plan. The target award is 18,423 PSUs, with a grant date fair value of $500,000, and potential payout from 0% to 140% of target.

The PSUs have a two-year performance period from January 1, 2026 through December 31, 2027, based on revenue and adjusted EBIT goals for the Cornell Dubilier business unit. Each year’s revenue and adjusted EBIT goals each control 25% of the target PSUs, with threshold, target, and maximum payouts set at 60%, 100%, and 140% of target, respectively. No PSUs vest until the Committee certifies results after the performance period, and continued employment is required, subject to specified Change of Control and termination provisions.

Rhea-AI Summary

Knowles Corporation filed an 8-K stating that it issued a press release with its financial results for the year and quarter ended December 31, 2025. The company also posted related presentation slides on its investor website.

Knowles scheduled a quarterly financial conference call and webcast for February 5, 2026, to discuss these results. The press release is furnished as Exhibit 99.1 and the presentation slides as Exhibit 99.2, giving investors access to detailed operational and financial information.

Rhea-AI Summary

Knowles Corporation filed an 8-K under Item 2.02 stating it has announced results for the quarter ended September 30, 2025. The company furnished a press release and presentation slides as Exhibits 99.1 and 99.2, and held its quarterly conference call and webcast on October 23, 2025. The materials are furnished, not filed, and therefore are not incorporated into Securities Act filings unless specifically referenced. The filing includes forward-looking statements language, noting estimates related to the expected impact, timing, and amounts of restructuring charges.